4

OWNERSHIP DOCUMENT

Company: Petros Pharmaceuticals, Inc.
Filed: January 25, 2023
Period of Report: January 20, 2023
Accession Number: 0001104659-23-006545

View Document ↗ View on SEC.gov ↗